Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Enhancing the Quality of Weight Loss Key Takeaway: Using creatine while on a GLP-1 medication shifts the weight loss profile toward fat loss
| Same drug, different doses | Clinical evidence at each dose | Side effects and tolerability | Practical differences | Cost and access in the UK | Who might benefit from each
It remains an investigational medicinal product (IMP), meaning its use is restricted to formally approved clinical trials conducted under a Clinical Trial Authorisation (CTA) issued by the MHRA, in accordance with the UK Clinical Trials Regulations
The Difference Matters Patients with Type 2 diabetes face different health considerations than otherwise healthy individuals seeking weight loss: Diabetes Patients: Already managing a chronic condition requiring medical monitoring Regular appointments with healthcare providers to track blood sugar Typically use lower doses focused on glucose control May have other diabetes medications that interact with GLP-1 drugs Often have existing gastrointestinal issues from diabetes itself Weight Management Patients: Often healthy individuals without chronic conditions May use higher doses prescribed specifically for weight loss Less frequent medical monitoring No existing reason to expect severe health complications Prescribed Ozempic off-label without FDA approval for this use When pharmaceutical companies aggressively marketed Ozempic for weight management despite FDA approval only for diabetes treatment, they expanded the population exposed to serious adverse effects
If you notice any of these, stop using the product and see a dermatologist
